At the time when we started to collect data, a total of 1068 HBsAg-positive patients attended our four centers. Among them, 922 (86.3%) were receiving nucleot(s)ide therapy, and 146 (13.7%) had a chronic inactive HBV infection. Table 1 reports the baseline characteristics of the 146 pat...